Synthesis and characterization of ordered mesoporous silica nanoparticles with tunable physical properties by varying molar composition of reagents

African Journal of Pharmacy and Pharmacology

Volumn 5, Issue 21, 2011, Pages 2402-2410

  Wanyika, Harrison ^a,c   Gatebe, Erastus ^a   Kioni, Paul ^b   Tang, Zhiyong ^c   Gao, Yan ^c  

^a JOMO KENYATTA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Kenya)

^b Kimathi University College of Technology   (Kenya)

^c NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

Author keywords

Mesoporous silica nanoparticles; Physical properties; Synthesis; Tuning

Indexed keywords

MESOPOROUS SILICA NANOPARTICLE; NANOPARTICLE; NITROGEN; REAGENT; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; BARRETT JOYNER HALENDA PORE SIZE; BRUNAURER EMMETT TELLER SURFACE AREA; CHEMICAL COMPOSITION; CHEMICAL PARAMETERS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYSTAL STRUCTURE; DESORPTION; DIFFERENTIAL SCANNING CALORIMETRY; INFRARED SPECTROSCOPY; NANOCHEMISTRY; NANOPORE; PARTICLE SIZE; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY; SYNTHESIS; THERMOGRAVIMETRY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 83155183379     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: 10.5897/AJPP11.592     Document Type: Article

References (48)

1. Barrett EP, Joyner LG, Halenda PP (1951). The determination of pore volume and area distributions in porous substances.1. Computations from nitrogen isotherms. J. Am. Chem. Soc., 73: 373-380.
2. Beck JS, Vartuli JC, Roth WJ, Leonowicz ME, Kresge CT, Schmitt KD, Chu CT-W, Olson DH, Sheppard EW, McCullen SB, Higgins JB, Schlenker JL (1992). A new family of mesoporous molecular sieves prepared with liquid crystal templates. J. Am. Chem. Soc., 114: 10834-10843.
3. Borisova D, Mohwald H, Shchukin DG (2011). Mesoporous silica nanoparticles for active corrosion protection. ACS NANO, 5(3): 1939-1946.
4. Bottini M, Annibale FD, Magrini A, Cerignoli F, Arimura Y, Dawson MI, Bergamaschi E, Rosato N, Bergamaschi A, Mustelin T (2007). Quantum dot-doped silica nanoparticles as probes for targeting of T-lymphocytes. Int. J. Nanomed., 2: 227-233.
5. Brunauer S, Emmett PH, Teller E (1938). Adsorption of gases in multimolecular layers. J. Am. Chem. Soc., 60: 309-319.
6. Cauda V, Argyo C, Piercey DG, Bein T (2011). "Liquid-Phase Calcination" of Colloidal Mesoporous Silica Nanoparticles in High-Boiling Solvents. J. Am. Chem. Soc., 133: 6484-6486.
7. Cauda V, Muhlstein L, Onida B, Bein T (2009). Tuning drug uptake and release rates through different morphologies and pore diameters of confined mesoporous silica. Micropor. Mesopor. Mater., 118: 435-442.
8. Chen J, Wang W, Xu Y, Zhang X (2011). Slow-Release Formulation of a New Biological Pesticide, Pyoluteorin, with Mesoporous Silica. J. Agric. Food Chem., 59: 307-311.
9. Coleman NRB, Attard GS (2001). Ordered mesoporous silicas prepared from both micellar solutions and liquid crystal phases. Micropor. Mesopor. Mater., 44-45: 73-80.
10. Courtney RT, Daniel PF, Jae-Hyun L, Eunjoo C, MiHyeon C, Eun SK, Stoddart JF, Jeon-Soo S, JinWoo C, Jeffrey IZ (2010). Noninvasive Remote - Controlled Release of Drug Molecules in vitro using Magnetic Actuation of Mechanized Nanoparticles. J. Am. Chem. Soc., 132: 10623-10625.
11. Cui D, Xu Q, Gu S, Shi J, Che X (2009). PAMAM-drug complex for delivering anticancer drug across blood-brain barrier in-vitro and in-vivo. Afr. J. Pharm. Pharmacol., 3(5): 227-233.
12. Feldmann C, Goesmann H (2010). Nanoparticulate Functional Materials. Angew. Chem. Int. Ed., 49: 1362-1395.
13. Gao C, Qiu H, Zeng W, Sakamoto Y, Terasaki O, Sakamoto K, Chen Q, Che S (2006). Formation mechanism of anionic surfactant-templated mesoporous silica. Chem. Mater., 18: 3904-3914.
14. Gerion D, Herberg J, Bok R, Gjersing E, Ramon E, Maxwell R, Kurhanewicz J, Budinger TF, Gray JW, Shuman MA, Chen FF (2007). Paramagnetic silica-coated nano-crystals as an advanced MRI contrast agent. J. Phys. Chem., C 111: 12542-12551.
15. Graf C, Dembski S, Hofmann A, Ruehl E (2006). A general method for the controlled embedding of nanoparticles in silica colloids. Langmuir. 22: 5604-5610.
16. Gu J, Fan W, Shimojima A, Okubo T (2007). Organic-inorganic mesoporous nanocarriers integrated with biogenic ligands. Small, 3: 1740-1744.
17. Hoffman F, Cornelius M, Morell J, Froba M (2006). Silica-Based Mesoporous Organic-Inorganic Hybrid Materials. Angew. Chem. Int. Ed., 45: 3216-3251.
18. Igor IS, Juan LV-E, Chia-Wen W, Victor S-YL (2008). Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 60: 1278 -1288.
19. Kobler J, Bein T (2008). Porous Thin Films of Functionalized Mesoporous Silica Nanoparticles. ACS NANO, 2(11): 2324-2330.
20. Kobler J, Moller K, Bein T (2008). Colloidal Suspensions of Functionalized Mesoporous Silica Nanoparticles. ACS NANO, 2(4): 791-799.
21. Leirose GDS, Cardoso MB (2011). Silica-Maltose Composites: Obtaining Drug Carrier Systems through Tailored Ultrastructural Nanoparticles. J. Pharm. Sci., 100(7): 2826-2834.
22. Limnel T, Santos HA, Makila E, Heikkila T, Salonen J, Murzin DY, Kumar N, Laaksonen T, Peltonen L, Hirvonen J (2011). Drug Delivery Formulations of ordered Mesoporous Silica: Comparison of Three Drug loading methods. J. Pharm. Sci. Published online, DO1.10.1002/ jps.22577.
23. Liu R, Liao P, Liu J, Feng P (2011). Responsive polymer-coated mesoporous silica as PH - sensitive nanocarrier for controlled release. Langmuir, 27: 3095-3099.
24. Mbaraka IK, McGuire KJ, Shanks BH (2006). Acidic mesoporous silica for the catalytic conversion of fatty acids in beef tallow. Ind. Eng. Chem. Res. 45: 3022-3028.
25. Naik SP, Elangovan SP, Okubo T, Sokolov I (2007). Morphology control of mesoporous silica particles. J. Phys. Chem., C 111: 11168-11173.
26. Niu D, Ma Z, Li Y, Shi J (2010). Synthesis of core-shell structured dual-mesoporous silica spheres with tunable pore size and controllable shell thickness. J. Am. Chem. Soc., 132: 15144-15147.
27. Nooney RI, Thirunavukkarasu D, Chen Y, Joseph R, Ostafin AE (2002). Synthesis of Nanoscale Mesoporous Silica Spheres with controlled particle size. Chemistry Mater., 14: 4721-4728.
28. Palmqvist AEC (2003). Synthesis of ordered mesoporous materials using surfactant liquid crystals or micellar solutions. Curr. Opin. Colloid. Interface Sci., 8: 145-155.
29. Popat A, Hartono SB, Stahr F, Liu J, Qiao SZ, Lu GQ (2011). Mesoporous silica nanoparticles for bioadsorption, enzyme immobilization, and delivery carriers. Nanoscale. DOI: 10.1039/c1nr10224a.
30. Popovici RF, Seftel EM, Mihai GD, Popovici E, Voicu VA (2010). Controlled Drug Delivery System Based on Ordered Mesoporous Silica Matrices of Captopril as Angiotensin-Converting Enzyme Inhibitor Drug. J. Pharm. Sci., 100(2): 704-714.
31. Radin S, El-Bassyouni G, Vresilovic EJ, Schepers E, Ducheyne P (2004). In vivo tissue response to resorbable silica xerogels as controlled-release materials. Biomaterials, 26: 1043-1052.
32. Salonen J, Lehto VP, Laine E (1997). The room temperature oxidation of porous silicon. Appl. Surf. Sci., 120: 191-198.
33. Shen S-C, Ng WK, Chia L, Hu J, Tan RBH (2011). Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: Effect of pore and particle size. Int. J. Pharm., 410: 188-195.
34. Shokri N, Javar HA, Fouladdel S, Khalaj A, Dinarvand R, Azizi E (2011). Preparation and characterization of crosslinked and non-crosslinked polycaprolactone fumarate (PCLF) NPs as carriers for doxorubicin HCl. Afr. J. Pharm. Pharmacol., 5(7): 797-805.
35. Sing KSW, Everett DH, Haul RAW, Moscou L, Pierotti RA, Rouquerol J, Siemieniewska T (1985). Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity. Pure Appl. Chem., 57: 603-619.
36. Slowing II, Trewyn BG, Lin VSY (2007). Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J. Am. Chem. Soc., 129: 8845-8849.
37. Speybroeck MV, Mellaerts R, Mols R, Thi TD, Martens JA, Humbeeck JV, Annaert P, Mooter GV, Augustijns P (2010). Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica. Eur. J. Pharm. Sci., 41: 623-630.
38. Stober W, Fink A, Bohn E (1968). Controlled Growth of Monodisperse Silica Spheres in the Micron size range. J. Colloid Interface Sci., 26: 62-69.
39. Suteewong T, Sai H, Cohen R, Wang S, Bradbury M, Baird B, Gruner SM, Wiesner U (2011). Highly animated mesoporous silica nanoparticles with cubic pore structure. J. Am. Chem. Soc., 133: 172-175.
40. Thommes M, Kohn R, Froba M (2000). Sorption and Pore Condensation Behavior of Nitrogen, Argon, and Krypton in Mesoporous MCM-48 Silica Materials. J. Phys. Chem., B104: 7932-794.
41. Vallet-Regi M (2009). Nanostructured mesoporous silica matrices in Nanomedicine. J. Int. Med., 267: 22-43.
42. Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS-Y (2010). Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery. Small. 6(18): 1952-1967.
43. Wen L-X, Li Z-Z, Zou H-K, Liu A-Q, Chen J-F (2005). Controlled release of avermectin from porous hollow silica nanoparticles. Pest Manag. Sci., 61: 583-590.
44. Yokoi T, Sakamoto Y, Terasaki O, Kubota Y, Okubo T, Tatsumi T (2006). Periodic Arrangement of Silica Nanospheres Assisted by Amino Acids. J. Am. Chem. Soc., 128: 13664-13665.
45. Yoo WC, Stein A (2011). Solvent effects on morphologies of mesoporous silica spheres prepared by pseudomorphic transformations. Chem. Mater., 23: 1761-1767.
46. Zhao XS, Lu GQ, Whittaker AK, Millar GJ, Zhu HY (1997). Comprehensive Study of Surface Chemistry of MCM-41 Using 29Si CP/MAS NMR, FTIR, Pyridine-TPD, and TGA. J. Phys. Chem., B101: 6525-6531.
47. Zhu C-L, Lu C-H, Song X-Y, Yang H-H, Wang X-R (2011). Bioresponsive Controlled Release Using Mesoporous Silica Nanoparticles Capped with Aptamer-Based Molecular Gate. J. Am. Chem. Soc., 133: 1278-1281.
48. Zhu MQ, Han JJ, Li Alexander DQ (2007). CdSe/CdS/SiO2 core/shell/shell nanoparticles. J. Nanosci. Nanotechnol., 7: 2343-2348.